Michael B. Zemel, Ph.D.

Michael B. Zemel, Ph.D.

Dr. Zemel comes to Kinexum from NuSirt Biopharma, where he serves as Chief Scientific Officer as well as company founder. At NuSirt, he developed and ran the discovery R&D program in metabolic health, leading to clinical stage asset development in obesity, diabetes and NASH.  He also led the NuSirt regulatory effort through Phase 2 in each of the company’s therapeutic areas and was responsible for clinical program development in each of these areas. Before starting NuSirt, he served as Professor of Medicine and of Nutrition at the University of Tennessee and prior to that was Professor of Endocrinology and Nutrition at Wayne State University with a concurrent position as Research Endocrinologist at the VA.  Dr. Zemel has authored or co-authored more than 200 clinical and basic peer-reviewed publications in numerous journals, including Proceedings of the National Academy of Sciences, New England Journal of Medicine, American Journal of Physiology, Endocrinology, Journal of Clinical Investigation, American Journal of Hypertension, PLoSOne, FASEB Journal, Metabolism, and Obesity.  He holds B.S., M.S. and Ph.D. degrees from the University of Wisconsin-Madison. 

Services Provided by Dr. Zemel include:

  • Translational drug product development
  • Regulatory and clinical development, including IND, regulatory communications and clinical protocols
  • Due diligence
  • Project management

Experts

Clinical Development

G. Alexander Fleming, MD

Arthur Santora, MD, Ph.D

Brian E. Harvey, MD, Ph.D

Charles Alexander, MD

Doug Muchmore, MD

Giora Davidai, MD

Gordon B. Cutler, Jr., M.D.

Grant Williams, MD

Guenther Karmann, Ph.D

John K. Whisnant, Jr, MD

Michael Trautmann, MD

Mustafa A. Noor, MD, FACP

Peter Damsbo, MD

Ramachandra (Ram) G. Naik, M.D.

Simon Bruce, MD

Theo Gana, MD, Ph.D

Todd J. Lorenz, MD

Regulatory Strategy and Operations

G. Alexander Fleming, MD

Arthur Santora, MD, Ph.D

Asoke Mukherjee, Ph.D

Brian E. Harvey, MD, Ph.D

Catherine Bernard, Ph.D

David Reinhold Brill, Ph.D

Dia Hill

Frances Mielach, Ph.D, RP.h

Gabrielle Wiederkehr, MSc

Grant Williams, MD

Joshua Sharlin, Ph.D

Michael Sharp, Ph.D

Susan Manley, MS

 Biostatistics

Alan Fisher, DrPH

EU Regulatory

Catherine Bernard, Ph.D

Gabrielle Wiederkehr, MSc

Michael Trautmann, MD

Clinical Operations/Project Management

Brian Oscherwitz, MBA, PMP

Chris Yun, B.S.

Gabrielle Wiederkehr, MSc

Julie Waltz Gerlach, B.S.N., M.P.H., R.A.C.

Susan Manley, MS

Pre-Clinical

Asoke Mukherjee, Ph.D

Dave Edwards, Ph.D

Frances Mielach, Ph.D, RP.h

Joy Cavagnaro, Ph.D

Michael B. Zemel, Ph.D.

Virgil Whitehurst, Ph.D

CMC, Formulation/Process Development & Sourcing

Anand Khedkar, Ph.D

David Bergstrom, Ph.D

Jo Van Betsbrugge, PhD

Knut Zellerhoff, Ph.D

Robert Kaster, RPh., ASQ-CQA

Medical Device

Michael Sharp, Ph.D 

QA/QC

Brian Oscherwitz, MBA, PMP

Jennifer Zhao, B.S.

 Medical Writing/Electronic Submissions

Jennifer Zhao, B.S.

Kristi Hultberg, B.S.

Sandor Bernath, Ph.D, MBA

Botanicals

Jinhui Dou, Ph.D.

Government Relations and Public Affairs

Scot Faulkner, MPA

Defense & National Security Practice

Dean E.Calcagni, MD

Commercialization and Business & Corporate Strategy

Brian Oscherwitz, MBA, PMP

Lisa Jansa, MBA

Martin Lafontaine

Thomas Seoh, J.D.